Cameron Mohammadi
Neurology · Washington, DCNPI 1407316334
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 96.5% of the total across 92 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 21 manufacturers reported payments, led by EMD Serono, Inc. at 32.5% of the total.
Across 92 payments — averaging $60.55 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- EMD Serono, Inc.$2K
- Sanofi$679
- TG Therapeutics, Inc.$445
- E.r. Squibb & Sons, L.L.C.$396
- Genentech, Inc.$377
- Bristol Myers Squibb$337
- plus $2K from 15 others
What the payments were for
- Food & beverage$5,37897%
- Education$1933%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| EMD Serono, Inc. | 22 | $1,810 |
| Sanofi | 7 | $679 |
| TG Therapeutics, Inc. | 4 | $445 |
| E.r. Squibb & Sons, L.L.C. | 3 | $396 |
| Genentech, Inc. | 4 | $377 |
| Bristol Myers Squibb | 5 | $337 |
| Novartis | 18 | $331 |
| Biogen | 4 | $262 |
| AstraZeneca | 5 | $169 |
| Merz Pharmaceuticals, LLC | 3 | $147 |
| AbbVie | 2 | $144 |
| Argenx US, Inc. | 1 | $99 |
| Amgen | 2 | $94 |
| ANI Pharmaceuticals, Inc. | 2 | $63 |
| Amneal Pharmaceuticals LLC | 3 | $59 |
| Lilly USA, LLC | 2 | $43 |
| Genentech USA, Inc. | 1 | $35 |
| Adamas Pharmaceuticals, Inc. | 1 | $23 |
| Avion Pharmaceuticals | 1 | $20 |
| Kyowa Kirin, Inc. | 1 | $18 |
| Ipsen Biopharmaceuticals, Inc | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$5,571 in reported general payments places this provider in the 60th percentile of 113 neurology providers in District of Columbia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Kesimpta PenOfatumumab | 18 | $167,019 |
| Dalfampridine ErDalfampridine | 19 | $12,988 |
| Baclofen | 12 | $466 |
| Prednisone | 15 | $46 |
Paid to pharmacies, not to this prescriber.
Other neurology in Washington
- Laxman BahrooWashington$3.1M
- Fahd AmjadWashington$2M
- Jessica AilaniWashington$1.2M
- Yasar Torres-YaghiWashington$969K
- Benjamin OsborneWashington$747K
- Fernando PaganWashington$690K
- Faria AmjadWashington$557K
- Brian BarryWashington$359K
- Carrie DoughertyWashington$327K
- Carlo TornatoreWashington$318K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.